Antiretroviral Therapy Changes for Medicare Beneficiaries With HIV Transitioning to Long-Term Care
JAMA Network Open 10.1001/jamanetworkopen.2025.48936December 12, 2025 at 11:00 AM EST
How do the days covered by antiretroviral therapy prescriptions change when Medicare beneficiaries with HIV transition from the community to a long nursing home stay?In this cohort study of 713 long stays for 657 individuals with HIV across 598 facilities, the proportion of days covered by antiretroviral therapy prescriptions increased by a mean intercept (α value) of 13.92 after transitioning to a nursing home. More than one-quarter of nursing home stays were without prescriptions for antiretroviral therapy before and after nursing home admission.These findings suggest that nursing homes can maintain or even improve existing engagement with antiretroviral therapy for people with HIV but still miss opportunities for treatment initiation.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.